The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 5, 1997, Pages 701-706

  Mulder, J G ^a   Kosterink, J G W ^b   Degener, J E ^b  

^a Public Health Service of Groningen   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CIPROFLOXACIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDATE SODIUM; GENTAMICIN; NETILMICIN; OXACILLIN; PENICILLIN G; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG USE; HOSPITAL CARE; HUMAN; INTENSIVE CARE; NONHUMAN;

EID: 0030786665     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.5.701     Document Type: Article

References (29)

1. Lowy, F. D. & Hammer, S. M. (1983). Staphylococcus epidermidis infection. Annals of Internal Medicine 99, 834-9.
2. Hamory, B. H., Parisi, J. T. & Hutton, J. P. (1987). Staphylococcus epidermidis: a significant nosocomial pathogen. Journal of Infection Control 15, 59-74.
3. Refsahl, K. & Andersen, B. M. (1992). Clinically significant coagulase-negative staphylococci: identification and resistance patterns. Journal of Hospital Infection 22, 19-31.
4. Milatovic, D. & Braveny, I. (1987). Development of resistance during antibiotic therapy. European Journal of Clinical Microbiology and Infectious Diseases 6, 234-44.
5. Oppenheim, B. A., Hartley, J. W., Lee, W. & Burnie, J. P. (1989). Outbreak of coagulase negative Staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. British Medical Journal 299, 294-7.
6. Kotilainen, F., Nikoskelainen, J. & Huovinen, P. (1990). Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. Journal of Infectious Diseases 161, 41-4.
7. Mouton, R. P., Hermans, J., Simoons-Smit, A. M., Hoogkamp-Korstanje, J. A. A., Degener, J. E. & van Klingeren, B. (1990). Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. Journal of Antimicrobial Chemotherapy 26, 573-83.
8. Cruciani, M. & Bassetti, D. (1994). The fluoroquinolones as treatment for infections caused by Gram-positive bacteria. Journal of Antimicrobial Chemotherapy 33, 403-17.
9. Weinstein, M. P., Reller, L. B., Murphy, J. R. & Liechtenstein, K. A. (1983). The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations Reviews of Infectious Diseases 5, 35-53.
10. Dominguez-de Villota, E., Algora-Weber, A., Millán, I., Rubio, J. J., Galdos, P. & Mosquera, J. H. (1987). Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. Intensive Care Medicine 13, 390-4.
11. Haverkorn, M. J. & Staal, M. J. (1987). An estimate for the source of coagulase-negative staphylococci in blood cultures. Epidemiology Infection 99, 333-41.
12. Bryan, C. S. (1989). Clinical implications of positive blood cultures. Clinical Microbiology Reviews 2, 329-53.
13. Ringberg, H., Thorén, A. & Bredberg, A. (1991). Evaluation of coagulase-negative staphylococci in blood cultures. A prospective clinical and microbiological study. Scandinavian Journal of Infectious Diseases 23, 315-23.
14. Falk, D. & Guering, S. J. (1983). Differentiation of Staphylococcus and Micrococcus spp. with the Taxo A bacitracin disk. Journal of Clinical Microbiology, 18, 719-21.
15. Hébert, G. A (1989). Antimicrobic susceptibility and other phenotypic tests that help identify and biotype coagulase-negative staphylococci. Antimicrobic Newsletter, 6, 9-18.
16. Rhoden, D. L., Hancock, G. A. & Miller J. M. (1993). Numerical approach to reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. Journal of Clinical Microbiology, 31, 490-3.
17. Kloos, W. E. & Wolfshohl, J. F. (1982). Identification of Staphylococcus species with the API Staph-ident system. Journal of Clinical Microbiology, 16, 509-16.
18. Schleifer, K. H. (1986). Micrococcaceae. In Bergey's Manual of Systemic Bacteriology (Sneath P. H. A., Mair N. S., Sharpe M. E. & Holt J. G., Eds), pp. 1003-6. Williams & Wilkins, Baltimore, MD.
19. Archer G. L. (1995). Staphylococcus epidermidis and other coagulase-negative staphylococci. In Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 1777-84. Churchill Livingstone, New York.
20. Mouton, R. P. & Klingeren B. (1981). Standaardisatie van Gevoeligheidsbepalingen. Verslag Werkgroep Richtlijnen gevoeligheidsbepalingen. Rijksinstituut voor de Volksgezondheid en Milieuhygiëne, Bilthoven.
21. Ericsson, H. M. & Sherris, J. C. (1971). Antibiotic sensitivity testing. Report of an International Collaborative Study. Acta Pathologica et Microbiologica Scandinavica 217, Suppl., 82-7.
22. Mulder, J. G. (1996). Comparison of disk diffusion, the E test, and detection of mecA for determination of methicillin resistance in coagulase-negative staphylococci. European Journal of Clinical Microbiology and Infectious Diseases 15, 567-73.
23. Courvalin, P. (1995). Impact of molecular biology on antibiotic susceptibility: testing and therapy. American Journal of Medicine 99, 21S-25S.
24. Møller, J. K. (1988). Drug resistance and plasmid profiles in Staphylococcus epidermidis in 1964 and 1986. Journal of Hospital Infection 12, 19-27.
25. McDougal, L. K. & Thornsberry, C. (1986). The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. Journal of Clinical Microbiology 23, 832-9.
26. Ubukata, K., Nonoguchi, R., Matsuhashi, M., Song, M. D. & Konno M. (1989). Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy 33, 1624-6.
27. Wolfson, J. S. & Hooper, D. C. (1985). The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 28, 581-6.
28. Neu, H. C. (1988). Bacterial resistance to fluoroquinolones. Reviews of Infectious Diseases 10, Suppl. 1, 57-63.
29. Møller, J.-K. (1989). Antimicrobial usage and microbial resistance in a university hospital during a seven-year period. Journal of Antimicrobial Chemotherapy 24, 983-92.